Categories: News

Phemex Launches Market Confidence Campaign to Support Traders Through Volatility

APIA, Samoa, Oct. 11, 2025 /PRNewswire/ — Phemex, the most efficient crypto exchange, today announced the launch of its Market Confidence Campaign, a global initiative designed to support traders during the current market downturn. Crypto markets have experienced broad declines across major assets in the past week, driven by macroeconomic uncertainty, deleveraging pressures, and weakening risk appetite. In response, Phemex is introducing practical incentives and cost-saving measures to help users maintain disciplined strategies and long-term confidence amid volatility.

- Advertisement -

Running from October 11 to October 31, 2025, the campaign supports both new and existing users through incentives that promote disciplined participation rather than emotional reactions to market conditions. The initiative is part of Phemex’s broader commitment to providing confidence in every market through practical tools, transparent processes, and responsible trading support.

- Advertisement -

The campaign includes:

- Advertisement -
  • Zero-Fee Trading Slots — 5,000 limited spots available, covering trading fees for eligible users during the campaign period.
  • 20% Deposit Cashback — Up to 200 USDT in bonus rewards for new users making qualifying deposits, available to the first 1,000 participants.
  • Referral Rewards — Users can earn up to 50 USDT per valid referee by sharing the campaign with friends, encouraging community engagement and broader access.

“Market downturns can be defining moments for disciplined traders,” said Federico Variola, CEO of Phemex. “This campaign embodies our belief that true confidence comes from preparation and access — not speculation. Alongside trading incentives, we remain focused on empowering users with knowledge and perspective, helping them navigate volatility with clarity and discipline. Phemex builds tools for resilience — not just when markets rise, but especially when they are tested.”

- Advertisement -

This campaign follows a series of recent product enhancements from Phemex like Multi-Assets Mode, all designed to give users greater capital control. As market sentiment recalibrates, Phemex continues to reinforce its mission of building a future where crypto trading remains accessible, efficient, and grounded in trust.

- Advertisement -

About Phemex

Founded in 2019, Phemex is the most efficient crypto exchange trusted by over 6 million traders worldwide. The platform offers spot and derivatives trading, copy trading, and wealth management products that combine seamless functionality with institutional-grade security. Known for its reliability and innovative edge, Phemex stands out for prioritizing user experience and transparency in an industry where trust is essential.

- Advertisement -

For more information, please visit: https://phemex.com/ 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2794112/Phemex_Launches_Market_Confidence_Campaign_to_Support_Traders_Through_Volatility.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/phemex-launches-market-confidence-campaign-to-support-traders-through-volatility-302581336.html

- Advertisement -

Recent Posts

Helport AI Completes Key Consumer Finance AI Labor Workflow, Advancing Toward Scalable Replication

SAN DIEGO and SINGAPORE, July 20, 2026 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ: HPAI)…

2 hours ago

Gatekeeper Unveils New Visual Identity to Reflect Its Natively Unified Architecture and Agentic Innovation

Now with full MCP support across every frontier LLM and a new Gatekeeper Chat experience,…

2 hours ago

CMG Announces Date for First Quarter 2027 Results and Conference Call

CALGARY, Alberta, July 20, 2026 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the…

2 hours ago

VERAXA Biotech Announces Regulatory Progress with its BiTAC-TCE Development Plan

ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging…

2 hours ago

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO and BYOOVIZ at ASRS 2026 Annual Meeting

July 20, 2026 07:00 ET  | Source: Harrow, Inc. NASHVILLE, Tenn., July 20, 2026 (GLOBE…

2 hours ago

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies

July 20, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel and HOBOKEN, N.J., July…

2 hours ago